2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Arrhythmias, Cardiac in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, JL; Carlquist, JF; Fang, WB; Huntinghouse, JA; Johnson, EG; Knight, S; Moody, DE; Rollo, JS; Webster, LR | 1 |
1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Arrhythmias, Cardiac
Article | Year |
---|---|
A Possible Mechanistic Link Between the CYP2C19 Genotype, the Methadone Metabolite Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidene (EDDP), and Methadone-Induced Corrected QT Interval Prolongation in a Pilot Study.
Topics: Adult; Alleles; Arrhythmias, Cardiac; Cytochrome P-450 CYP2C19; Electrocardiography; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Male; Methadone; Pharmacogenetics; Pilot Projects; Polymorphism, Single Nucleotide; Pyrrolidines; Time Factors; Young Adult | 2015 |